Skip to main content

Table 3 Associations between hyperoncotic albumin exposure and outcomes among the propensity score matched patients

From: Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?

Primary outcome

Albumin

N = 3600

Control

N = 3600

Odds ratio (95% CI)

(albumin/control)

P value

Acute kidney injury

  

1.10 (1.04, 1.17)

0.002

 No injury

2610 (72.5)

2699 (75.0)

  

 Stage 1 injury

729 (20.3)

704 (19.6)

  

 Stage 2 injury

104 (2.9)

90 (2.5)

  

 Stage 3 injury

157 (4.4)

107 (3.0)

  

Secondary outcomes

  

Odds ratio (98.3% CI)†

 

Liver injury

137 (3.8)

118 (3.3)

1.16 (0.85, 1.58)

0.25

In-hospital mortality

114 (3.2)

127 (3.5)

0.88 (0.64, 1.20)

0.32

   

Hazard ratio (98.3% CI) †

 

Length of ICU stay‡ (h)

64 [41, 119]

50 [29, 115]

0.95 (0.90, 1.00)

0.03

  1. †P value < 0.017 was considered significant (i.e., 0.05/3 = 0.017, Bonferroni correction)
  2. ‡Discharges for those patients who died in hospital were considered as non-events and censored at the longest observed length of stay